Roivant Sciences (ROIV) Non Operating Income (2021 - 2022)
Roivant Sciences (ROIV) posted Non Operating Income of $18.1 million for Q4 2022, up 404.12% on a QoQ basis from -$5.9 million in Q3 2022, and up 537.6% year-over-year from $2.8 million in Q4 2021.
Roivant Sciences (ROIV) Non Operating Income (2021 - 2022) Analysis & Trends
Roivant Sciences' Non Operating Income history runs 2 years deep, the most recent figure standing at $18.1 million for Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 18.10 Mn |
| Sep 30, 2022 | -5.95 Mn |
| Dec 31, 2021 | 2.84 Mn |
| Sep 30, 2021 | -2.20 Mn |